Niteesh Potu

Mr. Niteesh Potu

Johns Hopkins University School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JWJordi de Winkel
Jordi de Winkel
MJMathieu van der Jagt
Mathieu van der Jagt
HLHester F. Lingsma
Hester F. Lingsma
BRBob Roozenbeek
Bob Roozenbeek
ECEusebia Calvillo
Eusebia Calvillo
JSJose I. Suarez
Jose I. Suarez
Prior research suggests substantial between-center differences in functional outcome following aneurysmal subarachnoid hemorrhage (aSAH). One hypothesis is that these differences are due to practice variability. To characterize practice variability, we sent a survey to 230 centers, of which 145 (63%) responded. Survey respondents indicated that an estimated 65% of ruptured aneurysms were treated endovascularly. Sixty-five percent of aneurysms were treated within 24 h of symptom onset, 18% within 24–48 h, and eight percent within 48–72 h. Centers in the United States (US) and Europe (EU) treat aneurysms more often endovascularly (72% and 70% vs. 51%, respectively, US vs. other p < 0.001, and EU vs. other p < 0.01) and more often within 24 h (77% and 64% vs. 46%, respectively, US vs. other p < 0.001, EU vs. other p < 0.01) compared to other centers. Most centers aim for euvolemia (96%) by administrating intravenous fluids to 0 (53%) or +500 mL/day (41%) net fluid balance. Induced hypertension is more often used in US centers (100%) than in EU (87%, p < 0.05) and other centers (81%, p < 0.05), and endovascular therapies for cerebral vasospasm are used more often in US centers than in other centers (91% and 60%, respectively, p < 0.05). We observed significant practice variability in aSAH treatment worldwide. Future comparative effectiveness research studies are needed to investigate how practice variation leads to differences in functional outcome.

5 January 2025 in Neurotherapeutics
Verified
Journal Article
Open access
RMRohan Mathur
Rohan Mathur
LCLin Cheng
Lin Cheng
JLJosiah Lim
Josiah Lim
TATej D Azad
Tej D Azad
PDPeter Dziedzic
Peter Dziedzic
JSJose I. Suarez
Jose I. Suarez
A wide range of acute brain injuries, including both traumatic and non-traumatic causes, can result in elevated intracranial pressure (ICP), which in turn can cause further secondary injury to the brain, initiating a vicious cascade of propagating injury. Elevated ICP is therefore a neurological injury that requires intensive monitoring and time-sensitive interventions. Patients at high risk for developing elevated ICP undergo placement of invasive ICP monitors including external ventricular drains, intraparenchymal ICP monitors, and lumbar drains. These monitors all generate an ICP waveform, but each has its own unique caveats in monitoring and accuracy. Current ICP monitoring and management clinical guidelines focus on the mean ICP derived from the ICP waveform, with standard thresholds of treating ICP greater than 20 ​mmHg or 22 ​mmHg applied broadly to a wide range of patients. However, this one-size fits all approach has been criticized and there is a need to develop personalized, evidence-based and possibly multi-factorial precision-medicine based approaches to the problem. This paper provides historical and physiological context to the problem of elevated ICP, provides an overview of the challenges of the current paradigm of ICP management strategies, and discusses advances in ICP waveform analysis, emerging non-invasive ICP monitoring techniques, and applications of machine learning to create predictive algorithms.

20 July 2024 in Ophthalmology
Verified
Journal Article
Closed access
AAAbdelhalim A. Awidi
Abdelhalim A. Awidi
FWFasika A. Woreta
Fasika A. Woreta
ASAhmed Sabit
Ahmed Sabit
HHHaihong Hu
Haihong Hu
Niteesh PotuNiteesh Potu
Niteesh Potu
SVSuma Vupputuri
Suma Vupputuri